HHS wants to require nursing homes to disclose more ownership and management information; privacy advocates warn that mental health data can legally be sold from certain platforms not covered by the Health Insurance Portability and Accountability Act; the FDA won’t review Soligenix’s cancer drug proposal because of an insufficient application.
HHS Aims to Require Nursing Home Ownership Transparency
A new rule requiring nursing homes to offer more information on their ownership and management is being proposed by HHS, reported The Hill. Medicaid and Medicare enrolled nursing homes are required to release certain information on ownership and management, but the new rule would widen the realm of information offered so customers are fully aware of who owns, operates, and manages nursing homes, including if they are private equity investors or real estate investment trusts.
Sale of Mental Health Data Unprotected by Law
Data provided to telehealth and therapy apps are being sold by data brokers legally and without knowledge or consent, reported The Washington Post, citing the results of a study conducted by Duke University. The Health Insurance Portability and Accountability Act limits US health data shared by covered health entities like hospitals and doctor’s offices, but doesn’t protect information distribution through non-protected platforms, like some apps. A researcher was able to buy information from 11 companies, ranging from zip code level data to personally identifiable
FDA Won’t Review Soligenix’s Cancer Drug
On Tuesday, Soligenix said that its cancer drug proposal application won’t be reviewed by the FDA, which said it was incomplete, according to Reuters. The company wants the FDA’s assistance in helping the drug, HyBryte, move forward. The drug would be for the treatment of rare cancer T-cell lymphoma that starts in the white blood cells and attacks the skin.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More